Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCFA9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of January 12, 2026. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award contract valued at $499.999 billion with a completion date of December 31, 2036.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete in unrestricted federal procurement while maintaining consistent performance across multiple therapeutic categories. The company's portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with delivery orders ranging from under $100 to over $115,000. As one of multiple regional prime vendor contractors under the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group is positioned to serve Department of Defense healthcare operations globally, fulfilling diverse and specialized pharmaceutical requirements for military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FCFA9?
SPE2DR26FCFA9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FCFA9 worth?
The government has obligated $16,584 on SPE2DR26FCFA9.
Is contract SPE2DR26FCFA9 an order under another contract?
Yes. SPE2DR26FCFA9 is a delivery order under SPE2DR25D9130, an indefinite delivery contract.
Was contract SPE2DR26FCFA9 competed?
The extent of competition for SPE2DR26FCFA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award